KDIGO 2026 Clinical Practice Guideline for the Evaluation and Management of Anemia in Chronic Kidney Disease

Zusammenfassung

VOLUME 109 | ISSUE 1S | JANUARY 2026 www.kidney-international.org KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) SUPPLEMENT TO Kidney International(2026)109(Suppl 1S), S1–S99S1 KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) S3Tables,figures, and Supplementary Materials S7KDIGO Executive Committee S8Reference keys S9Current chronic kidney disease (CKD) nomenclature used by KDIGO S10Conv

Kerninformationen

methods of use for products that are referred to in the supplement by the authors may reflect their clinical experience or may be derived from the pro- fessional literature or other clinical sources. Because of the differences betweenin vitroandin vivosystems and between laboratory animal models and...

oss CKD stages, potential causes, and associated outcomes S31Figure 2. Mechanisms underlying anemia of chronic kidney disease S32Figure 3. Overview of iron deficiency in chronic kidney disease (CKD) with its definitions, prevalence across CKD stages, potential causes, and associated outcomes S33Fi...

ppendix Figure 4. Management of anemia and chronic kidney disease in kidney transplant recipients S99Appendix Figure 5. Management of anemia and chronic kidney disease in children www.kidney-international.orgcontents Kidney International(2026)109(Suppl 1S), S1–S99S3 SUPPLEMENTARY MATERIAL Appendix...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen